Clinical trial

Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer

NCT01440413

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2011-12-01

PhaseNA

Study timeline

Study start (actual)2011-12-01Date precision: month

Registry last updated2020-03-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Blood and tumor sampleBIOLOGICAL

Sponsors & collaborators

Centre Leon Berardlead sponsor

Mapped research locations

LyonFrance1 DijonFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01440413 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.